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ABSTRACT
SPERM MITOCHONDRIAL COPY NUMBER AND ASSOCIATIONS WITH
OXIDATIVE STRESS AND PHTHALATE METABOLITES IN MALE PARTNERS
UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES
MAY 2017
ALEXANDRA M. OLMSTED, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor J. Richard Pilsner

INTRODUCTION
Phthalates, a chemical class of plasticizers, are ubiquitous in the environment and recognized
as endocrine disrupting compounds (EDCs). Recent data suggest that oxidative stress is a
potential mediator of poor male reproductive health associated with phthalate exposure.
Mitochondria are implicated in the production of excess oxidative stress and sperm
mitochondrial copy number (MtCopy) and deletions (MtDeletion) have been linked with
male infertility. However, little is known about the relationship of these mitochondrial
biomarkers in sperm with phthalate exposure and oxidative stress.
OBJECTIVES
To examine associations of urinary phthalate metabolites and isoprostane concentrations on
sperm MtCopy and MtDeletions in male partners undergoing assisted reproductive
technologies (ART).
METHODS
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A total of (n=97) sperm samples were collected from male partners undergoing ART at
Baystate Medical Center, in Springfield, MA from 2014 to 2016 as part of the Sperm
Environmental Epigenetics and Development Study (SEEDS). Seventeen urinary phthalate
metabolites (n=103) were analyzed by the Centers for Disease Control using tandem mass
spectrometry. 15-F2t-Isoprostane (n=101) was measured using a competitive enzyme-linked
immonsorbent assay in urine of male individuals. A triplex Taqman probe-based qPCR
method was developed for relative quantification of genomic DNA, MtCopy and
MtDeletions. Multivariable linear or logistic regression was employed to examine
associations with age, BMI, batch and current smoking status with each outcome to
determine confounders used for adjustment.
RESULTS
Quartiles of MtCopy and MtDeletion were positively associated with the odds of male
infertility (p for trend < .0001 and 0.007, respectively). Urinary metabolite concentrations of
MCNP displayed a positive association with MtCopy (β=1.56; p =0.03). Urinary MEHP
concentrations were positively associated with MtDeletion in only infertile individuals
(n=30) (β = 0.075; p = 0.006). Urinary isoprostane concentration was not associated with
MtCopy or MtDeletion, but was associated with seven phthalate metabolite concentrations
(MEOHP, MEHHP, MBzP, MHBP, MiBP, and MHiBP).
CONCLUSIONS
To our knowledge, this is the first study to investigate the relationship between sperm
MtCopy and MtDeletion with oxidative stress and phthalates. These results suggest that
certain phthalate metabolites may be associated with a known biomarker of systemic
oxidative stress. Sperm mitochondrial function as measured by MtCopy and MtDeletion may
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be considered biomarkers of male infertility, although no relationship was shown between
mitochondrial outcomes and oxidative stress. Future research is investigating these
relationships with developmental outcomes including embryo quality.
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CHAPTER 1
INTRODUCTION
1.1. Introduction to Endocrine Disrupting Compounds
An endocrine disrupting compound is defined by the Endocrine Society as “an
exogenous [non-natural] chemical, or mixture of chemicals, that interferes with any aspect of
hormone action” (Gore AC et al., 2014). In the body, hormones are naturally produced within
glands that travel throughout the body and bind to specific receptors to trigger a response
(Gore AC et al., 2014). Endocrine disrupting compounds have been shown to act similarly to
the body’s naturally produced hormones and bind with androgen and estrogen receptors in
the body. Associations between a number of different identified EDCs and human health
issues have emerged as a major public health issue. Due to the nature of the endocrine
system, even endogenous hormones function at levels in the picomolar and nanomolar range
(Vandenberg LN et al., 2012). Environmentally relevant doses of EDCs have been associated
with adverse health effects (Attina TM et al., 2016). Low chronic doses of an EDC, or one of
its metabolites, have the ability to bind with receptors and alter estrogen or androgendependent gene expression by acting as an endogenous hormone. Even disruption of that
compound at a relatively few number of receptors may trigger a physiological change
(Vandenberg LN 2012).

1.2. Male Infertility and Reproductive Health
In 1992, it was suggested that sperm counts had declined by over 50% during the second
half of the last century (Carlsen et al., 1992). General fertility as measured by births per 1000
women aged 15-44 in 2010 was 37% lower than in 1950 (Damario MA 2014). While about
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half of all cases of infertility are attributed to the male partner, recent estimates suggest
defective sperm occurs in approximately 5% of all individuals (Aitken RJ et al. 2014; JM
Cambell et al 2015). Such declines have even been observed in donated sperm from males
living in Massachusetts region including disturbances in sperm count and motility between
2003 to 2013 (Centola GM et al. 2016). As these estimates have risen, so have increases in
testicular cancer (Purdue MP et al. 2005) and sex organ malformations (Aitken RJ et al.
2004) in humans over the past decades. Of particular relevance, testicular dysgenesis
syndrome (TDS) is considered the disorder related to in utero endocrine disrupting chemical
exposure and associated with disturbances in male development and affect fertility (te Velde
E et al. 2001). Men with poor quality semen parameters have been shown to have a higher
risk for other diseases including testicular cancer (Hanson HA et al 2016). Investigation of
semen quality parameters indicate their use in determination of overall health. A large study
of 43,277 men found an inverse relationship between the percentage of morphologically
normal and motile spermatozoa with mortality (Jensen TK et al 2009). Fertility status may
therefore be useful in evaluating overall men’s health.
There has been increasing desire for the use of assisted reproductive technologies (ART)
in the United States (Stephen EH et al. 2015). Recently, it has become evident that a variety
of developmental outcomes in progeny are related to the health status of the male fathers
undergoing ART (Eisenberg ML et al 2016). Additionally, adverse developmental outcomes
have been found in association with various adverse developmental outcomes (Smarr MM et
al., 2015). In humans, preconceptive paternal exposures including tobacco products (Sapra
KJ et al., 2016), persistent organic pollutants (Robledo CA et al., 2015), and bisphenol A and
phthalates (Buck Louis et al., 2014) have been shown to be associated with birth size
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(Robledo CA et al., 2015), longer time to pregnancy (Sapra KJ et al. 2016), and decreased
fecundity (Buck Louis et al 2014). Additionally, paternal preconceptive exposures have been
shown to contribute to birth outcomes in couples using ART (Dodge LE et al. 2015). In our
SEEDS population, paternal urinary concentrations of four phthalate metabolites were
inversely associated with high-quality blastocysts at the blastocyst stage (Wu H et al., 2017).
A number of studies have investigated birth and disease outcomes in association with the use
of ART, although the extent to which preconception paternal exposure contributes to
developmental outcomes remains undetermined.

1.2.1. Specific Times of Vulnerability to Male Germ Cell
The period of preconception has been increasingly recognized as an early window of
susceptibility of human development to environmental exposures. In its maturation process
from diploid to haploid called spermiogenesis, the male germ cell develops over a period
estimated to be 74 days in humans (Wu H et al 2015). During maturation, repair mechanisms
and apoptosis in response to damage are limited. Additionally, protection by the Sertoli cells
is lost as sperm formed in the epididymis continue along the male reproductive tract (Aitken
et al. 2004). Although mechanisms of repair are in place to handle sperm abnormalities, at
multiple time points after maturation the sperm can undergo changes that may alter their
ability to fertilize.

1.3. Phthalates
Phthalates diesters are a class of synthetic organic chemicals used in industrial and
consumer products. HMW phthalate products include uses in flexible vinyl plastics, medical

3

equipment, food packaging, and building materials such as flooring and wallboard.
Applications of LMW phthalates are typically included in personal care products, and
insecticides as solvents, fixatives, or alcohol denaturants (Johns LE 2015; ATSDR 1995,
2001; Zota AR et al 2014). Exposure routes typically include ingestion, inhalation, and
dermal absorption (Zota AR et al. 2014). Phthalate diesters are quickly metabolized to their
monoester form in the body. Measurement of phthalate metabolites have been found in urine
in sampling of the U.S population, of all ages, and worldwide (CDC, 2015). Acting similarly
to phthalates, newer phthalate alternatives may also have the potential to impact human
health, such as the parent compound DINCH. Phthalates are not covalently bond to products
and are therefore easily released into the environment (Meeker JD et al. 2009).
Biomonitoring data in the U.S from 2001-2010 have highlighted recent temporal changes in
the exposure profiles of phthalates found in urine. Since high molecular weight parent
phthalates have been found in association with reproductive health outcomes, alternative
phthalates such as DINCH have emerged in an effort to replace those with potential adverse
effects on human health (Zota AR et al. 2014).

1.3.1. Phthalates and Male Reproductive Health
Although some parent phthalates have been banned, much is left unknown about the
alternative compounds that have taken their place. Exposure to phthalates has been
associated with a number of poor health outcomes, including reproductive health. Formed
during hydrolytic and oxidative metabolic steps, the monoesters of the diester parent
compounds are believed to be responsible for toxicity (Lioy PJ et al., 2015). In humans,
phthalate exposure has the ability to disrupt the male reproductive system as evidenced by
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alteration of anogenital distance (Suzuki Y et al. 2012; Swan SH et al. 2015), sex steroid
hormone synthesis (Meeker JD et al. 2009), serum testosterone (Meeker JD and Furguson
KK 2014), sperm motility and concentration (Pant N et al 2014; Cai H et al. 2015), and by
sperm DNA damage (Hauser R et al. 2007). In addition to evidence in epidemiologic
findings, findings of phthalate exposure and male reproductive outcomes in animal models
include reduced sex organ weight (Shono T et al. 2014), abnormal Leydig cell aggregation
(Mahood IK et al. 2007), repression of sex determination (Wang YX et al. 2015), altered sex
ratio (Dobrynska MM et al. 2011) and delay in sexual maturity (Lee KY et al 2004). In
animal models, “phthalate syndrome” is used to describe adverse male reproductive health
outcomes due to androgen deficiency resulting from exposure to different parent phthalates
(Lioy PJ et al., 2015). Taken together, an estimated 240,100 cases of male infertility
resulting in the use of ART are reasoned to be due to Benzylphthalates (BBzP) and
butylphthalates (DBP) in males aged 20 to 39 in the United States. In addition, early
mortality attributed to phthalates and low testosterone in men aged 55 to 64 is estimated to be
10,700 cases in the United States (Attina TM et al 2016).

1.4. Oxidative Stress
Oxidative stress is characterized by the disruption of redox signaling and control
(Jones DP 2006). By endogenous and exogenous mechanisms of production of free radicals,
oxidative stress in the body can be triggered in the presence of a variety of chemical
compounds (Klaassen and Watkins 2010). Physiologically necessary as a major signaling
mechanism of intracellular proteins, the redox balance of prooxidant and antioxidants is
required for normal energy homeostasis in the body. Oxidative stress has been implicated in
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various diseases, including cancer and neurodegenerative disorders as well as male infertility
(Sedha S et al. 2015). Oxidative stress may cause lipid peroxidation and DNA fragmentation
to disrupt male fertility, although the mechanisms are not fully understood. A variety of
pathological outcomes by oxidative stress result from increases in reactive oxygen species
(ROS) or decreases in antioxidant defense mechanisms.

1.4.1. Phthalates and Oxidative Stress
Oxidative stress has been considered a potential mediator in phthalate-associated
reproductive outcomes. Several parent phthalate compounds have been implicated in
contributing to oxidative stress conditions by increasing ROS. Evidence of ROS induction in
human sperm has been shown in the parent compound DEHP and its metabolites in polyvinyl
workers, in addition to increased sperm apoptosis (Huang LP et al. 2014). The induction of
ROS was also shown by DEHP in human endometrial cells (Cho YJ et al. 2015). Phthalates
form hydroperoxides during their metabolism which have been shown to induce enzymes
responsible for antioxidation such as superoxide dismutatase (SOD) and GPx in animal
models (Agus HH et al., 2015). Similarly, those enzymes may become depleted and the body
may lose its ability to utilize this defense. In rats, treatment with DBP has been shown to
decrease testicular antioxidant enzymes (Aly HA, et al. 2016). Another study using a rodent
model, showed that MEHP, a metabolite of DEHP, increased superoxide generation and
resulted in decreased ATP production (Savchuk I et al., 2015). Additionally, mounting
evidence suggests that there are strong positive associations between urinary phthalate
concentrations and biomarkers of oxidative stress among pregnant women (Ferguson KK et
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al. 2014; Ferguson KK et al. 2015), both partners of couples planning pregnancy (Guo Y et
al. 2014), as well as among the general US population (Ferguson KK et al. 2012).

1.4.2. Mitochondria and Relation to Oxidative Stress
Mitochondria are responsible for energy-production in a cell. The circular, haploid
mitochondrial genome is 16kb in length and encodes 37 genes of which 13 are necessary for
the electron transport chain (Chen X et al., 2012). Mitochondria are connected to most ROS
production in the cell from leakage from the Electron Transport Chain. In most cells, 95% of
all free radical formation is due to this (Malik AN and Czajka A 2013). In sperm,
mitochondria are responsible for cellular energy production (ATP) necessary for their
motility and function (Gabriel MS et al. 2012) and form around the midpiece of the flagella
to form tight helix and allow propulsion (May-Panloup P et al., 2003). In addition, its other
roles include production steroid hormone, generation of FeS clusters, ion homeostasis, and
apoptosis (Demain LA et al 2016). Different cell types have been shown to have different
MtCopy, or number of copies of mitochondrial DNA (Phillips NR et al 2013). Additionally,
the mitochondrial genome may be susceptible compared to the nuclear genome due to its lack
of protective defenses such as histones, antioxidant containing cytoplasm, and DNA repair
mechanisms (Sutovsky P et al 2003).
Production of mitochondria can be triggered in situations where ROS have
overwhelmed its ability antioxidant system. Reactive oxygen species may overwhelm an
antioxidant system dealing with an oxidative stress to trigger production of mitochondria
(Zhong J et al. 2015). The relationship between mitochondrial abundance, as measured by the
ratio of mitochondrial DNA to nuclear DNA copy number, has been shown to be elevated in
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situations of oxidative stress in human leukocytes (Liu CS et al., 2003) however this
relationship is unknown in sperm. Mitochondrial copy number (MtCopy) is recognized as the
copies of MtDNA per spermatozoan and can be calculated using a target nuclear gene in
comparison to a nuclear single-copy gene. Mitochondrial copy number has been recognized
as a potentially useful biomarker of oxidative stress in humans. Increased copy number, or
mtDNA per spermatozoon, can result from a feedback responsive representative of defective
fragmented or mutated mtDNA (Lee HC et al. 2000). Defected mitochondria are often
proliferated (Andreu AL et al., 2009) and aborted apoptosis or abnormal spermatogenesis
may result in an increased copy number (Song GJ and Lewis V, 2008). When normal
biogenesis and degradation are not controlled by normal signaling processes under conditions
of oxidative stress, the processes that control the accumulation of damaged mitochondria
such as fission and mitophagy may result in and excess production of free radicals. The DNA
of these mitochondria may become further damaged by deletions or mutations which is in
close proximity to the excess ROS being generated (Malik AN and Czajka A 2013).
Because mitochondrial DNA elimination is expected to occur throughout sperm
maturation, low copy numbers are expected in normal sperm of men. A number of different
studies have shown that MtCopy is higher in sperm of infertile men, including those with
abnormal semen parameters. Using different methods, elevated mitochondrial copy number
per haploid genome has been found in association with poor sperm motility (MS Gabriel
2012), male infertility (Song and Lewis 2008, May-Panloup et al. 2003), and differential
global and gene-specific sperm DNA methylation (Tian M et al 2014). Additionally,
mitochondrial integrity has been shown to have inverse associations with semen parameters
(Song and Lewis, 2008). To investigate mitochondrial integrity, it is useful to measure a
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target sequence within an area known for its common deletions in reference to a sequence
region in the mitochondrial genome not known to have any deletions.

1.4.3. Isoprostane as a Biomarker of Oxidative Stress
Isoprostane is one commonly used measure of oxidative stress in vivo (Kadiiska et al
2005; Roberts LJ and Morrow JD 2002). In biomembranes, poly-unsaturated fatty acids, such
as arachidonic acid, are especially susceptible to insults of free radicals caused by conditions
of oxidative stress. F-2 isoprostanes are prostaglandin-like compounds formed
nonenzymatically on lipids by the autoxidation reaction between arachidonic acid and
oxygen to produce free radicals. Lipid peroxidation is well-recognized mechanisms in which
free radicals may cause harm to a system and lead to pathogenic injury and disease (Jacob
KD et al 2013). Because of the high amount of unsaturated fatty acids in spermatozoa, they
are considered highly susceptible to lipid peroxidation (RJ Aitken et al 2014).
Some isoprostanes are biologically potent and may they themselves lead to
pathogenic injury, although this has not been determined for all isoprostanes. In the presence
of hydrolyzing enzymes, isoprostane may be more present in its more bioactive form as free
acid than as estrified isoprostane. Isoprostane may be formed ex vivo in the presence of lipids
and therefore urine may be the most biologically accurate marker in part due to their low
lipid levels compared with other biological fluids (Roberts LJ and Morrow JD 1997).
Additionally, under proper storage conditions isoprostanes are stable. Spot urine samples
throughout the day and over a 24-hour period show considerable correlation (S Basu, 2008).
In urine, isoprostanes are recognized for their ability to indicate systemic oxidative stress.
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1.4.4. Oxidative Stress and Impact on Fertility
A conceivable pathway in which phthalate exposure may lead to oxidative stress is
shown in Figure 1. From publications, there is an indication that increases of ROS are related
to phthalates and therefore increased systemic oxidative stress, and phthalates are associated
with poor male reproductive health outcomes. Additionally, the literature suggests increases
in MtCopy and MtDeletion are indications of damaged MtDNA and are associated with male
infertility in sperm. Figure 1 shows a conceivable pathway by which phthalates impact
MtCopy and MtDeletion resulting in sperm damage. Both systemic oxidative stress and
sperm MtCopy and MtDeletion could be mediators in the relationship between phthalate
exposure and sperm damage. To our knowledge, the relationship between sperm MtCopy and
MtDeletion and isoprostanes and with phthalates has yet to be investigated.

Figure 1. Conceptual Diagram. Image represents a potential for phthalate exposure to
affect sperm quality and impact mitoch.
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CHAPTER 2
PROJECT RATIONALE
2.1. Project Rationale
The extent of this research thesis covers three main objectives. The first objective of
this research is the design of a TaqMan probe based qPCR triplex for use in simultaneously
quantifying mitochondrial copy number (MtCopy) and mitochondrial deletion (MtDeletion)
of sperm. The second objective is to analyze our findings of sperm MtCopy with urinary
phthalate metabolites of individuals enrolled in the Sperm Epigenetics and Development
Study (SEEDS) to examine associations. The third objective is to examine associations
between a known systemic biomarker of oxidative stress, urinary 15-F2t- Isoprostane, with
sperm MtCopy and MtDeletion. In addition to these findings other relationships with subsets
of the SEEDS population will be considered, including stratified analyses based on smoking
and infertility status.

2.2. Hypothesis Statement
For the first aim of this thesis, we hypothesis that the three targets can be used in one
simultaneous reaction to accurately measure MtCopy and MtDeletion in each human sperm
sample. Secondly, using statistical analyses and qPCR generated data for MtCopy and
MtDeletions, we hypothesis that MtCopy and MtDeletions will be positively associated with
phthalate metabolites. Lastly, we hypothesize that the biomarker of oxidative stress,
isoprostane, will be positively associated to MtCopy and MtDeletion in our population.
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CHAPTER 3
METHODS AND MATERIALS
3.1. Study Population
The first 103 individuals were chosen as part of a prospective cohort based out of
Baystate Medical Center Fertility Clinic in Springfield, Massachusetts. All participants
undergoing assisted reproductive technologies (ART) voluntarily provided clinic information
and specimens to the hospital to be used as part of the Sperm Environmental Epigenetics and
Development Study (SEEDS). Inclusion criteria for male participants include being 18-55
years of age using one’s own gametes for ART and providing written consent to physicians.
Institutional review boards at Baystate Medical Center, the University of Massachusetts
Amherst, and the Centers for Disease Control and Prevention (CDC) authorized this study.

3.2. Sperm Preparation
3.2.1. Procurement and Isolation
Remaining sperm after IVF were used from all volunteers after a two-day period of
abstinence. All samples were collected fresh on day of oocyte retrieval. Semen was purified
to sperm pellets by gradient centrifugation and RLT Buffer and TCEP were added to
preserve DNA and RNA.

3.2.2. DNA Extraction
Total genomic and mitochondrial DNA was extracted from isolate sperm using
QuiAMP DNA Mini Kit (Qiagen) via method by Wu H et al. 2015. Samples were either used
fresh or stored in -80oC.
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3.3. qPCR
3.3.1 Primer and Probe Design and Sequences
Primers and probes were chosen based on amplification efficiency and R2 values.
MinorArc was chosen as the mitochondrial target for use of derivation of copy number due to
similar efficiencies with other targets observed in tested reactions. In order to regard possible
interactions, all reactions were performed in combinations of singleplex and duplex before
being run in Triplex. Additionally, all reactions were tested in 10ul per well and 20ul per
well. The following Table 1 shows the sequences used for this assay.
Table 1. Primer and Probe Sequences for qPCR. Labeled sequences (Phillips NR et al. 2014)
for use in Triplex.
MinorArc
MajorArc
5’- CTA AAT AGC CCA CAC GTT CCC-3’
5’-CTG TTC CCC AAC CTT TTC CT-3’
FWD
Primer
5’- AGA GCT CCC GTG AGT GGT TA-3’
5’-CCA TGA TTG TGA GGG GTA GG-3’
REV
Primer
6FAM-CAT CAC GAT GGA TCA CAG GT- NED- GAC CCC CTA ACA ACC CCCProbe
MGBNFQ

MGBNFQ

3.3.2. Sperm Dilution
In order to maintain ~10ng/ul as a concentration, sperm genomic DNA were tested on
NanoDrop 2000/2000c Spectrophotometer (Thermo Scientific) and diluted to ~5ng/ul using
the formula C1V1=C2V2. If sample was below 5ng/ul, no dilution was performed.

3.3.3. Assay Reagents
Dilution of stock concentrations was performed for MinorArc Primers, MinorArc
probes, MajorArc primers, and MajorArc probes. The aforementioned were diluted to 5uM
with TE Buffer pH 8.0 from their stock concentrations of 100uM. See Appendix I for Pilsner
Lab Protocol for Relative Quantification. The following Table 2 shows reagents the volume
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and concentrations of each reagent used in the assay following dilution from stock
concentrations.
Table 2. Reagents used in each 10ul volume well.
Reagents
Volume
FAM labeled MinorArc Probe at 5uM
0.5uL
MinorArc Primer Mix at 5uM
0.5uL
NED labeled MajorArc Probe at 5uM
0.5uL
MajorArc Primer Mix at 5uM
0.5uL
VIC labeled RNAseP Primer/Probe Mix at 20x 0.5uL
Nuclease-free H2O
0.5uL
ProAmp 2x Master Mix
5uL
~5ng/ul DNA template
2uL
TaqMan probes were used for both mitochondrial targets and the nuclear target.
According to ThermoFisher Scientific, the use of fluorescent probes allow for high
reproducibility and sensitivity and assessment of low copy number variation. The choice was
two mitochondrial targets in this triplex was modified based on previous findings (Phillips
NR et al. 2014) for use with sperm. The MinorArc genomic sequence used in this assay is
located in the D-Loop where deletions have not been reported, and primer and probe target
regions are free of polymorphic sites. In addition, MinorArc was chosen, as opposed to other
mitochondrial targets tested, due to its lack of interaction with other targets and high
amplification efficiency. The MajorArc target used in this assay contains the “common”
deletion, recognized as a 4977 bp area with observed large deletions in humans with
mitochondrial syndromes (Moraes CT et al 1989), Alzheimer’s Disease (Corral-Debrinski M
et al 1994), ALS (Keenery PM and Bennett JP 2010), and prostate cancer (Reguly B et al.
2010) in somatic cells. Within our target region, our target spans about 84% of the known
Major Arc deletions (Phillips NR et al. 2014). RNAseP is a well-established nuclear
reference gene present in two copies in a diploid genome and has been designed by
ThermoFisher to serve as their recommended copy number reference assay in humans.
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Similarly, the ProAmp Taq Master Mix chosen was chosen based on its use in qPCR with
multiple targets and its use with copy number quantification.

3.3.4. qPCR Conditions
Conditions for activation and extension were based on Master Mix recommendations.
Annealing temperature of 55oC was used based on previous findings for this primer set and
checked by standard curve. The following conditions were used: 95oC for 10 minutes
activation, 95oC for 15 seconds, 55oC for 15 seconds and 60oC for 60 seconds.

3.3.5. Amplification Efficiency
The linearity and slope of the three targets across standards was used to verify their
respective acceptable amplification efficiencies. The standard curve was plotted with average
CT of triplicate wells for each target on the Y-axis and log DNA added to each reaction on
the X-axis. Trend line was added to series of each target across standards as well as adding
R2 values. R2 values are considered acceptable at values greater or equal to 0.99. The
amplification efficiencies of each target may be calculated using the slope of each trend line
across standards. The formula for efficiency of each target is calculated by the following
formula: E=10^(-1/slope), where the slope is calculated across all standard. Amplification
efficiencies are considered acceptable between 90-105%.

3.4. Copy Number and Integrity Derivation
3.4.1. Choice of Wells
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CT differences across triplicate samples which yield a standard deviation of >0.5 for
any one target were evaluated to determine which of the three wells should be eliminated, at
which time only duplicate measurements will be used. Duplicate measurements were used in
seventeen instances across all plates. Linearity and slope were used to regard amplification
efficiencies and R2 values for all targets on all plates for six-point standard curve.

3.4.2. Derivations of Mitochondrial Copy and Deletion
For each reaction per the following formula was used to determine mitochondrial
copy (MtCopy): 2^(meanCT), where CT=(RNAseP CT- MinorArc CT). Similarly, the
formula used for mitochondrial deletions (MtDeletions): 2^(meanCT), where
CT=(MinorArc CT- MajorArc CT). CT differences are found per reaction and averages
were based on CTs from triplicate measurements. Coefficients of variation for calculated
copy numbers on each plate were <10%.

3.4.3. Validation Using Digital PCR
To validate our qPCR method, we measured eight repeated samples on a digital PCR
machine (QuantStudio 3D Digital PCR System), which provides absolute concentrations
(ThermoFisher Scienfic).

3.5. Urinary Phthalate Measurement
3.5.1. Sample Procurement and Storage
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Urine analyses of phthalates were performed from a spot urine sample from SEEDS
participants. Urine was collected in a sterile polyproplyene cup on the same day as the semen
sample, vortexed, separated into 10 ml aliquots, and frozen at -80ᵒC at UMass Amherst.

3.5.2. Measurement of Urinary Phthalate Metabolites
All urine specimens were shipped to the CDC on dry ice. Measurement of seventeen
different urinary phthalate metabolites was performed by the Centers for Disease Control
using enzyme deconjugation, solid-phase extraction, and tandem mass spectrometry as
described (Kato et al. 2005). The following seventeen urinary phthalate metabolites were
analyzed: Mono(2-ethylhexyl) phthalate (MEHP); Mono(2-ethyl-5-hydroxyhexyl) phthalate
(MEHHP); Mono(2-ethyl-5-oxohexyl) phthalate (MEOHP); Mono(2-ethyl-5-carboxypentyl)
phthalate (MECPP); Monocarbxyisooctyl phthalate (MCOP); Mono-isononyl phthalate
(MNP); Monobenzyl phthalate (MBzP); Mono (3-carboxypropyl) phthalate (MCPP);
Monocarboxy-isononly phthalate (MCNP); Mono-n-butyl phthalate (MBP); Mono-3hydroxybutyl phthalate (MHBP); Mono-isobutyl phthalate (MiBP); Mono-hydroxyisobutyl
phthalate (MHiBP); Mono-ethyl phthalate (MEP); Mono-methyl phthalate (MMP);
cyclohexane-1,2-dicarboxylic acid-monocarboxy isooctyl ester (MCOCH); and cyclohexane1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester (MHiNCH). One phthalate metabolite
(MMP) was not performed on the second batch of measurement by the CDC. Limits of
detection (LOD) varied between batches and ranged from 0.1 to 0.9 ng/mL across all
metabolites. Values falling under the LOD for each metabolite on each plate were
transformed to become the LOD/ 2. Parent phthalate and phthalate alternative diester
chemical structures and formulas of the above metabolites are included in Appendix II.

17

3.5.3. Dilution Correction and Log Transformation
Specific gravity was measured in urine by the CDC or by Baystate Reproductive
Clinic using a handheld refractometer for participants (Atago Co., Ltd., Toko, Japan). The
formula for dilution normalization of phthalate measurement by specific gravity is
Pc=P[(SGm-1)/(SG-1)] where SGm is the median SG value of all samples, SG is the specific
gravity value for that individual urine samples, and P is the measured phthalate metabolite
concentration. Values were log transformed for analyses.

3.6. Urinary 15-F2t-Isoprostane
3.6.1. Sample Preparation
A competitive enzyme-linked immunoassay was used to measure urinary 15-F2t
isoprostane of 102 samples (Cat#: EA84, Oxford Biomedical Research). In preparation of
urine, -glucuronidase was added to each sample and heated for two hours at 37oC as a
pretreatment to dilution. The purpose of this step is to allow for more free isoprostane which
has been found to be conjugated as glucuronic acid (>50%) (Yan Z et al. 2010) so treatment
allows for higher extraction of 15-F2t-IsoP. As per protocol, 5ul of glucuronidase was added
for every 100ul of urine. Samples were then diluted with kit’s dilution mix. Dilution factors
were dependent on specific gravities of each sample, with most having a dilution factor of 5.
15-F2t-isoprostane conjugated horseradish peroxidase competes on the antibody encoded 96well microplate with 15-F2t-isoprostane in each sample. Intensity can be read after adding
TMB substrate and sulfuric acid. The limit of detection is 0.2ng/mL. In addition, two control
samples were run on all plates.
3.6.2. Concentration Quantification
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A seven-point standard curve was run in duplicate with known stock standard.
Additionally, a Reagent Blank (RB) with no conjugate, and a B0 containing no sample or
standard were performed in duplicate. The calculation of 15-isoprostane F2t was performed
using the manufacturer’s calculation template, where duplicate well absorbance values were
taken. Samples with CV>15% were repeated. Each plate was read twice on a SpectraMax M2
microplate reader (Molecular Devices). A Solver add-in program for Excel was used to fit
the standard curve concentrations to find the percent of maximum binding (Frontline Solver).
For each sample, the average the RB was subtracted from the average OD between
duplicates. That value was divided by the percent of maximum binding (%B/B0) which was
achieved by solving the function using each actual standard versus the predicted value. All
values were then corrected for dilution using their specific gravities as previously mentioned
for phthalates.

3.7. Statistical Analyses
To examine the distributions of SG-corrected phthalate metabolites and isoprostane
concentration, geometric means were taken in addition to selected percentiles. Pearson
correlation was achieved to examine the relationship between MtCopy numbers derived from
digital PCR and qPCR. A Welsh two-sample t-test was used to determine if phthalate
metabolites, isoprostane, and mitochondrial endpoints were significantly different between
fertile and infertile men. Generalized linear regression models (GLM) were used to examine
the relationship between MtCopy and MtDeletion with different phthalate metabolites and
isoprostane. Additionally, GLM were used to assess the relationship between phthalate
measurements with urinary isoprostane. Covariates were chosen based on biological
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plausibility or those found in bivariate analyses to be associated with phthalate metabolites,
isoprostane, or mitochondrial outcomes. Included covariates used in adjusted analyses were
age, BMI, current smoking, batch phthalate, and batch mitochondrial target. Current smoking
was determined using a Cotinine ELISA kit (Calbiotech Cat#: CO096D). To further explore
differences between individuals classified with male factor infertility and those without,
stratified analyses were additionally performed. Logistic regression was used to consider the
odds of infertility by quartile of mitochondrial outcomes (MtCopy and MtDeletion), after
adjustment for covariates. Analyses were performed using R version 0.99.903 (R Core Team
2016, Vienna, Austria).
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CHAPTER 4
RESULTS
4.1. Triplex Standard Curve
Figure 2 shows a typical standard curve used in assessing efficiency in the design of
this assay with 10ng of sperm DNA from three individuals. The three targets are shown to
have similar amplification efficiencies within the desired range of 90-105%. Additionally,
the R2 values are shown to be acceptable for all targets in repeated trials and therefore
acceptable for use with SEEDS specimen (R2>0.99).

Standard Curve of Triplex
33.000
31.000
29.000

CT value

27.000

RNAseP

25.000
23.000
21.000
19.000
17.000

MajorArc
y = -3.4313x + 31.603
MinorArc
R² = 0.99779
Amp.Eff=95.63% y = -3.4598x + 29.909
R² = 0.99964
Amp.Eff=94.55%

15.000
0.000

0.500

MajorArc
MinorArc

RNAseP
y = -3.4724x + 29.723
R² = 0.99946
Amp.Eff=94.08%

1.000
1.500
2.000
Log DNA of Standard Added(ng)

2.500

Figure 2. Standard Curve of Triplex. qPCR CT results for three targets across log gDNA
concentration with associated amplification efficiencies and R2.

4.2. Demographic Statistics
The study population includes males seeking fertility treatment at Baystate Medical
Center. Table 3 outlines the breakdown of smoking, alcohol, BMI, age, race, and fertility
status of male individuals. Data used to determine BMI, age, and fertility at time of specimen
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collection was assessed by physicians. Individuals were determined to have male factor
infertility by hospital staff based on 2010 WHO sperm quality 5th centile reference values
including concentration <15 million/mL, total motility < 40% motile, and normal forms <4%.
Alcohol and smoking usage history was determined by an optional questionnaire provided to
each participant in the study. Percentage of no response was fairly even for childhood
exposure to smoking, current drinking, and age of first drink (21%, 16.5%, 19.4%,
respectively). Additionally, about 43% of participants refused to provide information on race
or were missing questionnaire data. Current smoking was determined using a Cotinine
ELISA kit (Calbiotech Cat#: CO096D) and eight smokers were identified.
The average age of male partners was 35.8 9 ± 5.37 years old and the majority of
individuals were between the ages of 30 and 40 (60%). The average BMI was 29.67 ± 6.06.
Approximately 36% of individuals are classified as overweight (BMI between 25-29.9),
while close to 40% of individuals could be classified as obese (BMI>30). The study
population is made up of approximately 29% infertile males, based on WHO guidelines.
Approximately 51.45% of participants identify as white, although close to 43% of the
population refused to answer or have missing data from the questionnaire. Childhood
exposure to smoke, defined by presence of someone in the household smoking while under
the age of 18, was 36.9% in this population. The majority of individuals identify as current
drinkers (80.60%), and approximately 45% of the total population recorded their age of first
drink as under 18.
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Table 3. Population demographics of SEEDS male partners

4.3. Descriptive Statistics of Metabolites
Distribution of specific gravity adjusted urinary phthalate metabolite concentrations
(ng/mL) for male individuals in this study are included in Table 4. Table 4 presents
geometric means and selected percentiles of each metabolite. For twelve metabolites, the
percentage of samples with limits of detection greater than 90% and include MEOHP,
MEHHP, MECPP, MBzP, MBP, MHBP, MHiBP, MMP, MCOP, MEP, MCPP, and MCNP.
For two metabolites of DINCH, a phthalate alternative, limits of detection were 38.8% for
MCOCH, and 63.1% for MHINCH; these were among the lowest percent detected in
addition to MNP. Highest geometric mean concentrations of urinary phthalate metabolites
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include MEP, followed by MCOP, and MECPP. All three of these metabolites had detection
frequencies <90%.
Table 4. Geometric means and selected percentiles of phthalate metabolites. Urinary
phthalate metabolite concentrations represent male partners of SEEDS participants.

4.4. Descriptive Statistics of Mitochondrial Outcomes and Isoprostane
Figures 3 and 4 show violin plots for MtCopy and MtDeletion data, respectively. The y-axis
represents to MtCopy number, or MtDeletion value. Inter-assay CVs for MtCopy and
MtDeletion were 2.4% and 2.8%, and intra-assay CVs were 4.77% and 7.83%. Table 5
presents the geometric means of MtCopy, MtDeletion, and Isoprostane (IsoP) with selected
percentiles, where values for IsoP are expressed in ng/mL. The median and geometric mean
of MtCopy in our population was 1.75 and 1.89, with an IQR of 1.59. For MtDeletion, the
median and geometric mean are 0.2 and 0.17 and the IQR is 0.15. The median and geometric
mean of isoprostane are values of 3.49 and 3.46 ng/mL, and the IQR is 1.91 ng/mL.
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Figure 3. Violin plot of MtCopy (n=97)

Figure 4. Violin Plot of MtDeletion (n=97)
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Table 5. Geometric means and selected percentiles of IsoP, MtCopy, and MtDeletion. Values
represent urinary IsoP concentration (ng/mL) and sperm MtCopy and MtDeltion

4.5. Digital PCR
The use of digital PCR (dPCR) allows for the absolute measurement of the target
DNA. Using two specific targets, our MinorArc mitochondrial target and our nuclear
RNAseP, we were able to validate that the method we developed can accurately measure
MtCopy in sperm samples. With the use of QuantStudio3D Digital PCR system by
Thermofisher Scientific, absolute copy number in our qPCR was compared to dPCR. Figure
5 represents the values achieved from each method for the eight samples.

Figure 5. MtCopy Yields from Two Methods. Values from eight samples by
using digital PCR and Triplex in qPCR.

Figure 6 shows a scatter plot of MtCopy yields derived from the two methods shown with a
line of linear model. Pearson correlation between dPCR and qPCR are comparable, given the
high R2 value (rho>0.99; p-value <0.001).
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Figure 6. dPCR and Triplex qPCR MtCopy yields

4.6. Comparisons of Phthalate Metabolites
4.6.1. SEEDS and CDC
Figure 7 shows a comparison of urinary phthalate metabolite concentrations between
two sources, after correction for dilution. The sources of data presented in the Figure 7 are
the CDC Fourth report on human exposure to environmental chemicals from the National
Health and Nutrition Examination Survey (NHANES) between 2011-2012 as well as the
participants of the SEEDS study.
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Figure 7. Comparison of Urinary Phthalate Metabolites from Two Sources. Figure shows
thirteen total metabolites geometric means from SEEDS and NHANES.

A comparison of 95% confidence intervals of geometric mean derived from
NHANES data published by the CDC in addition to the SEEDS data for 103 individuals.
Two metabolites, MHINCH and MCOCH, are excluded in the Figure 7 due to
geometric means and 50th percentile falling below LOD for NHANES data. One metabolite,
MHBP, was not provided in the CDC Fourth report and is not reported. Also, due to
geometric means falling under LODs, the 50th percentile is shown for metabolites MNP and
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MMP. Three metabolites have higher geometric means in SEEDS participants than in those
reported by the CDC (MCNP, MBP, MIBP).
4.6.2. Differences Among SEEDS individuals
Mean concentrations of specific gravity corrected phthalate metabolite concentrations
were evaluated for differences between fertile and infertile groups. Metabolites MBzP and
MEP showed borderline significant differences between mean concentrations in fertile and
infertile men (1.4 ± 1.1 ng/mL vs. 1.8 ± 1.0 ng/mL and p=0.074; 3.2± 1.3 ng/mL vs. 3.6 ± 1.0
ng/mL and p=0.054, respectively) while MCNP was shown to be significantly higher among
infertile men (1.0 ± 0.6 ng/mL vs. 1.3 ± 0.8 ng/mL and p=0.025). Both MtCopy and
MtDeletion were found to be significantly lower in fertile men than in infertile males (1.8 ±
1.1 vs. 6.2 ± 7.1 copies and p=0.005; 0.18 ± 0.09 vs. 0.23 ± 0.07 deletions and p=0.004,
respectively). No differences were observed for specific gravity adjusted isoprostane
concentrations between the two groups. Additionally, there were no differences between
isoprostane concentrations or MtDeletion between smokers and non-smokers, while there
was a borderline significant difference in means between the two for MtCopy (2.1 ± 0.8 vs.
3.0 ± 4.3 copies and p=0.079), although the sample size of current smoking was only of eight
individuals.

4.7. Linear Regression Analyses
4.7.1. MtCopy
Table 6 presents beta estimates from adjusted linear regression models of changes in
sperm MtCopy number associated with 1ng/mL concentration increase in urinary phthalate
metabolite or isoprostane concentration. Models were adjusted by batch phthalate, batch
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qPCR, age, BMI, and current smoking. Although DINCH metabolites show low percentages
of detection, the two were still treated as other metabolites with respect to their log
transformed SG adjusted value.
Table 6. Effect estimates using generalized
linear regression for MtCopy (n=97)
MEHP
MEOHP
MEHHP
MECPP
MCOP
MNP
MBzP
MCPP
MCNP
MBP
MHBP
MiBP
MHiBP
MMP1
MEP
MCOCH
MHINCH
IsoP

Estimate (95% CI) p-value
0.29 (-0.82, 1.40)
0.61
-0.02 (-1.16, 1.13)
0.98
-0.17 (-1.29, 0.95)
0.77
-0.12 (1.27, 1.03)
0.84
0.22 (-0.67, 1.11)
0.62
0.31 (-0.77, 1.39)
0.58
0.36 (-0.50, 1.22)
0.42
-0.24(-1.30, 0.83)
0.66
1.56 (0.16, 2.95)
0.03
0.09 (-0.99, 1.16)
0.88
-0.25(-1.60, 1.10)
0.72
-0.29 (-1.40, 0.82)
0.61
-0.48 (-1.55, 0.59)
0.38
-0.11 (0.48, -1.06)
0.82
0.11(-0.66, 0.87)
0.79
-0.26 (-1.39, 0.87)
0.65
-0.41 (-1.29, 0.48)
0.37
-0.05 (-0.15, 0.04)
0.28

Models adjusted for age, BMI, batch (qPCR;
phthalate),
and current smoking
1
Adjustment did not include batch phthalate (n=50)

One metabolite, MCNP, was shown to be positively associated with MtCopy (=1.56 (0.16,
2.95), p= 0.03). Figure 8 reflects the effect estimates shown in Table 6. Additionally,
MtDeletion and MtCopy were found to be in significant correlation (Pearson rho=0.27; pvalue <0.008).
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Figure 8. GLM Effect Estimates of MtCopy. Bars represent 95% confidence intervals (n=97)

To further consider differences, models were stratified by fertility status. Although
neither estimate for MCNP in stratified analyses were significant, both showed positive
effect estimates (=0.345 (-0.15, 0.84) for fertile men; =2.59 (-1.75, 5.55) for infertile men),
as shown in Table 7. In fertile men only, metabolites MNP and MCOP showed borderline
significant positive associations with MtCopy. Neither in whole population nor stratified
analyses was isoprostane found to be associated with MtCopy. Table 7 provides estimates of
generalized linear regression models of stratified analyses for MtCopy.
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Table 7. Stratified linear regression estimates of MtCopy. GLM estimates with 95%
confidence intervals (CI) and significance of MtCopy in stratified analyses of SEEDS male
individuals for Fertile (n=72) and Infertile (n=25)
Fertile

Infertile
p-value
Estimate (95% CI) p-value
MEHP
0.43
MEHP
2.33 (-2.97, 7.64)
0.4
MEOHP
0.94
MEOHP
-3.15 (-8.38, 2.07)
0.26
MEHHP
0.84
MEHHP
-2.21 (-6.98, 2.55)
0.38
MECPP
0.86
MECPP
-2.50 (-6.81, 1.80)
0.27
MCOP
0.08
MCOP
1.88 (-1.79, 5.55)
0.33
MNP
0.08
MNP
0.22 (-4.46, 4.90)
0.93
MBzP
0.25
MBzP
0.78 (-3.15, 4.72)
0.7
MCPP
0.2
MCPP
-0.66 (-4.90, 3.57)
0.76
MCNP
0.18
MCNP
2.59 (-1.75, 6.92)
0.26
MBP
0.99
MBP
1.29(-3.52, 6.10)
0.61
<0.003 (-0.33, 0.34)
MHBP
-0.01(-0.45, 0.43)
0.95
MHBP
-0.99 (-8.03, 6.06)
0.79
MiBP
-0.05 (-0.41, 0.30)
0.77
MIBP
-0.32 (-4.14, 3.49)
0.87
MHiBP
-0.02 (-0.36, 0.31)
0.89
MHIBP
-0.36 (-5.08, 4.36)
0.88
MMP1
-0.04 (-0.55, 0.46)
0.87
MMP1
-1.22 (-5.84, 3.40)
0.62
MEP
0.10 (-0.12, 0.32)
0.4
MEP
0.068 (-3.91, 4.04)
0.97
MCOCH
-0.10 (-0.42, 0.22)
0.56
MCOCH
0.15 (-5.45, 5.76)
0.96
MHINCH -0.12 (-0.39, 0.15)
0.38
MHINCH -0.34 (-3.99, 3.16)
0.86
IsoP
-0.02 (-0.16, 0.12)
0.78
IsoP
-1.82 (-4.23, 0.58)
0.16
Models adjusted for age, BMI, batch (qPCR; phthalate), and current smoking
1Adjustment did not include batch phthalate
Estimate (95% CI)
0.13 (-0.19, 0.45)
-0.01 (-0.35, 0.33)
-0.04 (-0.37, 0.30)
-0.03(-0.39, 0.32)
0.24 (-0.03, 0.50)
0.29 (-0.03, 0.61)
-0.15 (0.40, 0.10)
0.23 (-0.12, 0.59)
0.35 (-0.15, 0.84)

4.7.2. MtDeletion
Table 8 shows adjusted linear regression models of MtDeletion on phthalate
metabolites and IsoP concentrations. Models are adjusted for age, BMI, batch phthalate,
batch qPCR, and current smoking. No phthalate metabolite was found in significant
association with MtDeletion. Additionally, isoprostane concentration was not associated with
MtDeletion. Figure 9 reflects the effect estimates and 95% confidence intervals of Table 8.

32

Table 8. Effect estimates using generalized
linear regression for MtDeletion (n=97)
Estimate (95% CI)
p-value
MEHP
0.02 (-0.004, 0.043)
0.1
MEOHP
0.002 (-0.023, 0.026)
0.9
MEHHP
0.005(-0.020, 0.029)
0.71
MECPP
0.003(-0.022, 0.027)
0.84
MCOP
0.006 (-0.013, 0.025)
0.55
MNP
0.011 (-0.012, 0.034)
0.35
MBzP
0.007(-0.012, 0.025)
0.47
MCPP
0.006 (-0.017, 0.029)
0.6
MCNP
0.021 (-0.010, 0.051)
0.19
MBP
0.015 (-0.008, 0.037)
0.21
MHBP
0.015 (-0.014, 0.044)
0.3
MiBP
0.014 (-0.010, 0.037)
0.26
MHiBP
0.003 (-0.020, 0.026)
0.82
1
MMP
<-0.001(-0.037, 0.036)
0.96
MEP
0.008 (-0.009, 0.024)
0.36
MCOCH -0.004 (-0.028, 0.021)
0.78
MHINCH -0.002 (-0.021, 0.017)
0.82
IsoP
0.0002 (-0.010, 0.011)
0.96
Models adjusted for age, BMI, batch (qPCR;
phthalate), and current smoking
1Adjustment did not include batch phthalate
(n=50)

Figure 9. GLM Effect Estimates of MtDeletion. Bars represent 95% confidence intervals
(n=97)
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In stratified analyses (Table 9), metabolite MEHP was shown to be positively associated with
MtDeletion in only infertile men (=0.076 (0.029, 0.123); p= 0.006). Additionally,
MtDeletion was not found in association with isoprostane in either analysis.
Table 9. Stratified linear regression estimates of MtCopy. GLM estimates of MtDeletion on
phthalates metabolites and IsoP in stratified analyses of Fertile (n=72) and Infertile (n=25)
SEEDS participants
Fertile

Infertile
Estimate (95% CI)
p-value
Estimate (95% CI)
MEHP
0.015 (-0.011, 0.041)
0.26
MEHP
0.076 (0.029, 0.123)
MEOHP <-0.001 (-0.029, 0.027)
0.95
MEOHP
-0.012(-0.072, 0.049)
MEHHP
0.001 (-0.026, 0.029)
0.92
MEHHP
0.002(-0.052, 0.057)
MECPP
-0.003 (0.032, 0.026)
0.82
MECPP
0.007(-0.042, 0.057)
MCOP
0.008 (-0.014, 0.030)
0.49
MCOP
0.022 (-0.018, 0.063)
MNP
0.013 (-0.013, 0.040)
0.34
MNP
0.013 (-0.038, 0.065)
MBzP
0.005 (-0.016, 0.026)
0.64
MBzP
-0.007 (-0.051, 0.037)
MCPP
0.013 (-0.016, 0.043)
0.37
MCPP
0.005 (-0.042, 0.053)
MCNP
0.015 (-0.026, 0.057)
0.47
MCNP
0.019 (-0.031, 0.068)
MBP
0.011 (-0.017, 0.038)
0.46
MBP
0.036 (-0.015, 0.087)
MHBP
0.013 (-0.023, 0.049)
0.49
MHBP
0.006 (-0.073, 0.085)
MiBP
0.016 (-0.014, 0.045)
0.3
MIBP
-0.003 (-0.046, 0.040)
MHiBP
0.004 (-0.024, 0.031)
0.8
MHIBP
-0.025 (-0.076, 0.026)
MMP1
-0.006 (-0.046, 0.034)
0.78
MMP1
-0.022(-0.121, 0.077)
MEP
0.011 (-0.007, 0.029)
0.24
MEP
-0.031 (-0.072, 0.011)
MCOCH <-0.001 (-0.027, 0.026)
0.98
MCOCH -0.029 (-0.090, 0.032)
MHINCH
0.003 (-0.019, 0.025)
0.81
MHINCH -0.026 (-0.065, 0.013)
IsoP
0.002 (-0.009, 0.013)
0.72
IsoP
-0.021 (-0.048, 0.006)
Models adjusted for age, BMI, batch (qPCR; phthalate), and current smoking
1Adjustment did not include batch phthalate

p-value
0.006
0.7
0.93
0.77
0.3
0.62
0.76
0.83
0.47
0.19
0.88
0.89
0.35
0.67
0.17
0.37
0.21
0.14

4.7.3. Isoprostane
Seven metabolites were found in association with isoprostane in adjusted linear
regression analyses, as shown in Table 10 (MEOHP, MEHHP, MBzP, MBP, MHBP, MiBP,
MHiBP). All of the seven associations displayed a positive relationship with IsoP. Figure 10
reflects effect estimates shown in Table 10.
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Table 10. GLM Effect Estimates for IsoP. Estimates reflect urinary phthalate metabolites in
SEEDS male partners (n=101)
Metabolite
Beta (95% CI)
p-value
MEHP
0.35 (-0.14, 0.84)
0.16
MEOHP
0.67 (0.18, 1.16)
0.008
MEHHP
0.54 (0.06, 1.03)
0.03
MECPP
0.34 (-0.15, 0.86)
0.17
MCOP
0.03 (-0.37, 0.42)
0.89
MNP
-0.05 (-0.54, 0.43)
0.82
MBzP
0.40 (0.02, 0.78)
0.04
MCPP
0.18 (-0.29, 0.66)
0.45
MCNP
0.03 (-0.61, 0.67)
0.93
MBP
0.62 (0.16, 1.07)
0.01
MHBP
0.63 (0.05,1.22)
0.04
MiBP
1.04 (0.60, 1.47)
<0.001
MHiBP
0.85 (0.41, 1.29)
<0.001
1
MMP
0.32 (-0.33, 0.96)
0.34
MEP
0.09 (-0.25, 0.43)
0.6
MCOCH
-0.07 (-0.57, 0.44)
0.79
MHINCH
0.32 (-0.07, 0.71)
0.11
Models adjusted for age, BMI, batch (qPCR; phthalate),
and current smoking
1
Adjustment did not include batch phthalate

Figure 10. GLM Effect Estimates (95% CI) of IsoP
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4.8. Logistic Regression Analyses
Because odds ratios for infertility were positively associated with both MtCopy and
MtDeletion in adjusted logistic regression analyses for age, BMI, batch, and current smoking,
odds ratios of infertility by both quartile of MtCopy and quartile of MtDeletion were
investigated. The odds ratios of infertility was borderline significant and significant for the
third (OR=7.65 (1.15, 14.15), p= 0.08) and fourth (OR=69.69 (63.09, 76.38), p= <0.001)
quartile of MtCopy. An odds ratio of infertility was significant for the fourth quartile of
MtDeletion (OR=7.72 (3.00, 12.44), p= 0.02). The relationship between IsoP and odds of
infertility did not reach significance. Figure 11 and Figure 12 reflect the odds ratios of
infertility by quartile of MtCopy and MtDeletion. Additionally, the following tables reflect
Fertility Status by Quartile of MtCopy (Table 11) or by Quartile of MtDeletion (Table 12).

Figure 11. Odds Ratios of Infertility by Quartile of MtCopy
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Figure 12. Odds Ratios of Infertility by Quartile of MtDeletion
Table 11. Fertility Status by Quartile of MtCopy
Quartile Fertile Infertile Total
1
23
2
25
2
21
3
24
3
19
5
24
4
9
15
24

Table 12. Fertility Status by Quartile of MtDeletion
Quartile Fertile Infertile Total
1
22
3
25
2
21
3
24
3
15
9
24
4
14
10
24
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CHAPTER 5
DISCUSSION
5.1. Trends in Phthalate Metabolites in our Population
Highest concentrations of phthalate metabolites of the seventeen include MEP,
MECPP, and MCOP. Although the trend over the past decade has been downward for the
former two metabolites, MCOP has steadily increased. With the exception of two phthalates,
MNP and MEP, the highest concentrations of all phthalate metabolites are observed in the
youngest population aged 6-11 years old according to data from the CDC. MEP had one of
the highest concentrations in our study, and individuals over the age of 20 are shown to have
the highest levels compared to different age groups. After urinary dilution correction only
two metabolites, MNP and MMP, are shown to be higher in males than females according to
NHANES date, although statistical differences are not known. Comparing geometric mean
values in our study to NHANES derived phthalate metabolite concentrations, MCNP, MBP,
and MiBP were shown to be higher in our sample of 102 individuals. MCNP, a metabolite of
DiDP, has been shown to fluctuate in its trend, as NHANES data reflects both increases and
decreases over the past decade. According to updated tables of 2011-2012, MCNP is among
one of only two metabolites in which caucasians are shown to have the highest
concentrations compared to other ethnicities. Considering the racial makeup of our
population from those who responded in the questionnaire, this may not be surprising
because most identify as white. Metabolites MnBP and MiBP, both of the parent compound
DBP, are higher in our population although the trend has been shown to be increasing for
only MiBP in a larger national sample.
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5.2. Consistencies with other studies and Potential Pitfalls
When comparing our urinary IsoP to those of other studies, it is important to consider
discrepancies between methods as well as manufactured ELISA assays. Concentrations of
isoprostane and phthalates in our study were corrected by specific gravity and not creatinine.
Our method has been considered to be favorable in dilution correction of urine in studies of
biological monitoring (Sauve JF et al 2015), however correction differences limit our ability
to make direct comparisons of our values to others reported. Lastly, the presence of
isoprostane is not believed to be cause of disease but rather a consequence of the oxidative
stress.
Our MtCopy numbers were fairly consistent with others reported. Other studies using
real-time PCR reported a range and average MtCopy similar to values yielded in this assay,
in a similar population consisting of some infertile men (May-Panloup et al 2003). It is
promising that our results from logistic regression showing highest quartile of MtCopy is
positively associated with odds of infertility considering that most studies report findings that
suggest men with abnormal sperm have a higher MtCopy number compared to their normal
sperm (Kao et al 2004; Gabriel MS et al 2012). Considering male factor infertility is
determined by semen parameters, these findings are in line with more recent studies that have
evaluated MtCopy number and sperm count and motility in a larger sample (Zhang G et al.
2016).
The method of DNA extraction has been shown to alter MtCopy number. One study
has indicated that the method of DNA extraction can affect the calculation of relative
MtCopy using a qPCR approach (Guo W et al., 2009). The QIAmp DNA Mini Kit was
shown to recover approximately 78% of both mitochondrial DNA and nuclear DNA in tested
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DNA of mouse liver cells and was used with the samples in our study. The QIAmp DNA kit
showed improved mtDNA: nDNA ratios than the other tested column-based silica assay and
performed comparable to isolation using phenol-chloroform/isoamyl alcohol extraction
method (PCIAA) method, which yielded approximately 85% of the two DNA types. Future
studies should take into account DNA extraction methods so measurement can most precisely
portray these outcomes.
All urinary analyses are performed on spot urine samples taken at the same time as
semen procurement and oocyte retrieval. A number of studies have determined that urinary
phthalate metabolites profiles may be consistent with a three-month period of time or longer
(Townsend MK et al. 2013; Christensen KL et al. 2012; Hauser R et al. 2004; Teitelbaum SL
et al. 2008). Also, longer chain phthalates including DEHP, DiBP, and DiDP may not have as
long temporal stability as those with shorter chains such as DBP, DEP, DiBP, and BBzP
(Johns LE et al 2015). In our study the sperm used for all assisted reproductive technologies
is taken at the same time of urine collection and is indicative of the same period of one’s
recent phthalate exposure and spermiogenesis. Additionally, our biomarker of oxidative
stress F2t-isoprostane is shown to have a short half-life of approximately 16 minutes
(Kaviarasan S et al 2009) which also is reflective of recent exposure of phthalates.

5.3. Metabolites of Interest
MCNP, Monocarboxy-isononly phthalate, is a metabolite of the high molecular
weight parent compound Di-isodecyl phthalate (DiDP). The parent compound is mostly used
in construction products in home dwellings, consumer products, and clothing
(Saravanabhavan G and J Murray 2012). It is also shown to be similar to DINP, and the two
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are often used interchangeably in industrial products as a replacement for DEHP. The
secondary oxygenated metabolites are shown to yield higher urinary excretion concentrations
than the monoester metabolite. Estimates of average daily intake in the United States is
<1ug/kg/day across numerous age, race, and gender subsets. Based on the lowest found
NOAEL of this compound, the tolerable daily intake of 150ug/kg/day is used by regulatory
Consumer Product Safety Commission (Kransler KM et al 2013). The study used in
derivation of the NOEAL used for this guideline was performed on three male and female
dogs, for assessment with organ weights and histology in subchronic study (Hazelton, 1968).
Overall little evidence suggests that DiDP is antiandrogenic. One study by Exxon Mobil, a
producer of DiDP, found in all dose groups had lower percent of normal sperm in male rats
(Exxon Mobil 1997), at doses ranging from 103 to 361 mg/kg body weight per day. In our
study, estimates of intake would be two orders of magnitude less than the tolerable daily
intake, and yet we are seeing effects at these low doses. Additionally, little evidence of
induction of oxidative stress exists for this parent compound. In assessment of ear tissue
homogenate of mice orally given 200mg/kg/day of DIDP, significant increases in ROS
production and decreases in glutathione were observed (Shen S et al. 2016).
Sperm parameters are used as a proxy of infertility. In our population, the hospital
determines male factor fertility status. In our study, mean concentrations of three phthalate
metabolites concentrations were found to be different between men considered fertile and
infertile. In linear regression analyses of the entire population, MCNP was shown to be
associated with MtCopy number in our SEEDS population. Although the relationship did not
maintain statistical significance in stratified analyses, this could be due to loss of power due
to small sample size. Because the effect estimates were both positive, it is an indication that
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the relationship may be appreciable. Although stratifying was performed by fertility to see
effect estimates, analyses were not adjusted by fertility status. Although it is possible that
phthalate exposure and mitochondrial targets are both related to infertility, it would not be
appropriate to adjust for infertility status because it is not expected that infertility would
predate mitochondrial proliferation or phthalate exposure along a temporal sequence. Control
for fertility status in regression models could introduce a bias. Stratification allows us to
make guesses about phthalate exposure and mitochondrial outcomes on fertility status but
would not induce an association between its causes.

5.4. Systemic Isoprostane and Relation to Sperm MtCopy
In this study, we also assessed urinary isoprostane, which is considered to be a gold
standard in evaluation of systemic oxidative stress partially owing to the low-lipid content in
urine. However, because seminal isoprostane was not assessed, the extent to which lipid
peroxidation takes place on local conditions in the male germ cell or reproductive organs
remains unclear. Because semen is known to have a high lipid content, it is especially
susceptible to oxidative injury by lipid peroxidation (Moazamian R et al 2015). It was shown
that men with normospermatic men have lower poly-unsaturated fatty acids than those with
asthenozoosperm and may therefore be more vulnerable to lipid peroxidation (Calamera J et
al., 2003). No known studies have established the relationship between levels of seminal
isoprostane and urinary isoprostane. Urinary isoprostane continues to be recognized for its
stability over time and its ability to represent chronic oxidative stress. For this reason,
temporal sequence of oxidative stress and infertility can be reasoned. Additionally, infertile
and fertile males in this study were not shown to have significant differences in
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concentrations of isoprostane. Previous studies have shown that seminal free isoprostane
concentrations were higher in men with seminal parameter abnormities, however their study
size was small and we measured systemic oxidative stress in urine and not semen (A
Khosrowbeygi and N Zarghami 2007). This same study showed that men with abnormal
sperm had higher levels of polyunsaturated fatty acids, namely docosahexaenoic acid (DHA),
and this was positively associated with mitochondrial ROS generation (Koppers AJ et al.
2010). Isoprostanes are formed by the autooxidation of arachidonic acid, which we used in
this study to assess systemic oxidative stress. Perhaps associations between sperm MtCopy
and sperm specific targets of lipid peroxidation such as DHA, a known main target in sperm,
would be more appropriate to assess this relationship (RJ Aitken et al. 2014). However
conditions that lead to sperm specific oxidative stress and systemic oxidative stress are not
mutually exclusive, considering exposures such as phthalates are shown to increase oxidative
stress in a number of different cell types.
Phthalates have been shown to induce apoptosis by reduction of enzymes necessary in
antioxidant defense. Because disruption of apoptosis may influence spermiogenesis, it has
been hypothesized that oxidative stress mediates this relationship. Additionally, it is
theorized that dysfunction of mitochondria lead to issues with the mitochondrial membrane
potential and in intracellular balance of proteins that regulate apoptosis (Fu G et al 2016;
Dunn JD et al. 2015). Mitochondria in sperm have been shown to increase ROS generation.
Apoptosis has been found in close association to increases in lipid peroxidation (Hamilton
TR et al. 2016), and decreases in catalase and glutathione peroxidase (Madhubabu G et al.
2014). Additionally, mitochondria are considered potential targets of EDCs (Xia W et al.,
2014), which have been shown to lead to decreased ATP production (Lin Y et al., 2013).
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Mitochondrial injury can be the result of disturbances in the respiratory chain which lead to
aberrations in controlled apoptosis (Fu G et al., 2017; Kaur K et al., 2014). Sperm apoptosis
can result under conditions of oxidative stress, and the ability for phthalates to lead to
apoptosis and increases in ROS has been documented in testicular cells (Shen H et al., 2015;
Yang J et al., 2012; Alam MS et al., 2016) and germ cells (Erkekoglu P et al., 2012) and in
humans (Wang XY et al., 2016). MtDeletion and MtCopy are both indicative of defected
mitochondria, which may result from increases in ROS from the presence of phthalates. The
result of the failure to eliminate mitochondria could be influencing apoptosis of sperm and
therefore inducing issues with fertility.
To our knowledge, this is the first study to examine both relative mitochondrial copy
number and deletions in a triplex reaction using TaqMan probes in sperm of men of this
population, and the first to look at these parameters in reference to phthalate concentrations.
While a number of studies have investigated sperm parameters including concentration,
motility, and total volume in infertile men, only one has looked at the relationship to
mitochondrial copy number and a class of environmental pollutants. In a recent cross
sectional study of 666 males, significant percent decreases in mitochondrial copy number
were found in association with increases in four urinary PAH metabolites (Ling X et al.
2017). Although more evidence is available to suggest increased MtCopy with poor
reproductive outcomes, decreases in mtDNA content have been found in men with
asthenospermia or <20% motility, compared to those with normal sperm (Kao SH et al.
2004). In our study there is evidence that there is no optimal range of MtCopy, as there is
evidence that the higher the value, the more evidence of higher odds of infertility.
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The exact process of mtDNA elimination in sperm over spermiogenesis and up until
fertilization remains unclear. Spermatozoa are believed to have between 22 and 80
mitochondria per cell (St. John JC et al., 2000) and about 2-10 copies of mtDNA are
predicted per mitochondrion (Rajender S et al., 2010). There is some indication that the
mitochondrial membrane potential allows for selection of the most degraded mitochondria to
be eliminated. By the time of implantation, paternal mtDNA are believed to be almost
completely degraded (Song WH et al., 2014). During disruption or damage mitochondria
may undergo mitophagy, or selective removal. Under physiological circumstances changes in
fission, fusion, shape, and localization allow mitochondria to respond to changes and selfeliminate (Song WH et al., 2014). A controlling factor that regulates MtCopy throughout
spermiogenesis is mitochondrial transcription factor activator mtTFA. TFAM aids in
protecting mtDNA from injuries of oxidative phosphorylation and it is down regulated
throughout the process (Rajender S et al., 2010). Because sperm may be especially
vulnerable to oxidative injury, it could be biologically beneficial to have decreased MtCopy
in sperm that can be damaged by ROS (Rajender S et al., 2010). Additionally, optimal sperm
mtDNA thresholds have been theorized (Wai T et al., 2010) although undetermined. Ten men
in our study had MtCopy higher than five, and nine of those individuals were infertile.
Gradient centrifugation was used to isolate motile sperm and therefore discern the best
quality sperm for use in ART; despite this, we still found positive associations with
infertility. This may be suggestive that MtCopy less than five is optimal. In our study, we
found indications of phthalate associated oxidative stress but we did not find a relationship
between MtCopy and phthalates or MtCopy and systemic oxidative stress. It could be that a
relationship between MtCopy and MtDeletion with oxidative stress was missed in our study

45

population due to our biomarker. Although it has been evidenced that increases in ROS
impact MtCopy and MtDeletion, the control of mitochondrial elimination may be more
tightly controlled in sperm. In sperm MtCopy and MtDeletion does not seem to be a
representative biomarker for systemic oxidative stress and phthalate exposure is not shown to
be associated these measurements.

5.5. Future Directions
Further investigation shall include the use of inflammatory markers and potentially
the measurement of isoprostane in semen to consider the potential relationship. Additionally,
the relationship between these mitochondrial outcomes to sperm parameters and phthalates to
sperm parameters will be further assessed. A future direction will also be to examine into
developmental outcomes and embryo quality.

5.6. Conclusions
Because phthalates are ubiquitous, the public health relevance of this research is
clear. Indications of perturbations in sperm mitochondria have reproductive health
implications, as the ability to recognize associations with sperm quality can affect overall
health. An understanding of mitochondrial copy number and integrity are novel tools in
determinations of male infertility. Although this study did not find associations between
oxidative stress, it could be owing to the unique and complicated nature of sperm. It is fairly
evident from this research that phthalates may not be impacting the failure to eliminate
mitochondria or the deletion proportion. Another potential mediator between phthalate
exposure and mitochondria in sperm could have been missed. This approach is especially
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relevant to understanding the role of oxidative stress in the body, in accompaniment with a
well-established biomarker of oxidative stress, during the time of preconception. This study
is particularly innovative because it is the only study to simultaneously quantify
mitochondrial copy and mitochondrial deletions in human sperm to examine associations
with both urinary phthalate concentrations in a fertility setting.
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APPENDIX I
PILSNER LAB PROTOCOL FOR RELATIVE QUANTIFICATION
Sperm Mitochondrial Copy and Deletion Relative Quantification
Equipment and Materials Needed
StepOnePlus Real-Time PCR System (Applied Biosystems # 4376600)
StepOne Software v2.3 (Applied Biosystems)
NanoDrop2000 UV-Vis Spectophotometer (ThermoFisher Scientific)
Lowbinding 1.5mL tubes
Reagents
TaqMan RNAseP Assay VIC-QSY 20x(Applied Biosystems # A30064)
TaqPath ProAmp Master Mix (Applied Biosystems # A30865)
IDTE Buffer pH 8.0 (1x TE Solution) (IDT #11-01-02-05)
Nuclease Free Water
Primer Sequences
FWD MinorArc: 5’- CTA AAT AGC CCA CAC GTT CCC-3’
REV MinorArc: 5’- AGA GCT CCC GTG AGT GGT TA-3’
FWD MajorArc: 5’-CTG TTC CCC AAC CTT TTC CT-3’
REV MajorArc: 5’-CCA TGA TTG TGA GGG GTA GG-3’
Probe Sequences
MinorArc: 6FAM-CAT CAC GAT GGA TCA CAG GT-MGBNFQ
MajorArc: NED- GAC CCC CTA ACA ACC CCC-MGBNFQ
A. Sperm DNA Preparation and Dilution
(If sperm is already diluted, skip to Part B.)
1. Isolate DNA using Qiagen AllPrep Kit via Pilsner lab protocol (Wu et al 2015)
2. Determine concentration of DNA using NanoDrop system
3. Dilute sperm DNA to ~5ng/ul using C1V1=C2V2. If sample is below 5ng/ul, do not
dilute sample.
B. Standard Curve Preparation
1. Remove 3ul of sperm from each sample and combine into 1.5mL low binding tubes.
Vortex.
2. Determine concentration on NanoDrop of combined sample.
3. Label tubes Standard 1-6. Add 50ul of TE Buffer to tubes labeled Standards 2-6. Add
50ul of Standard 1 into Standard 2. Repeat 1:1 Serial Dilutions. Keep Standards in
4C.
C. Reagent Preparation
Before starting: MasterMix should be kept in 4C. All primers and probes may be kept at 4o C
for up to ten weeks or may go through up to ten freeze thaw cycles. Keep stocks in -25C.
1. Dilute MinorArc probe to 5uM from its stock concentration of 100uM. For example,
create 5uM probe mix for a 300ul final volume by adding 285ul of TE Buffer 8.0
with 15ul of the probe stock. Vortex for 30 seconds.
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• Repeat step 1 for MajorArc
2. Create a Primer Mix at 5uM for MinorArc with each of its Forward and Reverse
primer stocks at a concentration of 100uM. For example, create 5uM primer mix for a
300ul final volume by adding 270ul of TE Buffer 8.0 with 15ul of the MinorArc
Forward Primer Stock and the MinorArc Reverse Primer Stock. Vortex for 30
seconds.
• Repeat step 2 for MajorArc
3. Plan Super Master Mix depending on the number of samples being run. In every 10ul
reaction, total volumes of each reagent are included on the following table:
Reagents
FAM labeled MinorArc Probe at 5uM
MinorArc Primer Mix at 5uM
NED labeled MajorArc Probe at 5uM
MajorArc Primer Mix at 5uM
VIC labeled RNAseP Primer/Probe Mix at 20x
Nuclease-free H2O
ProAmp 2x Master Mix
~5ng/ul DNA template

Volume
0.5uL
0.5uL
0.5uL
0.5uL
0.5uL
0.5uL
5uL
2uL

•

4.
5.
6.
7.

For a 96-well plate with 20% error, combine 576ul Master Mix with 57.5ul of
all reagents (excluding DNA)
Prepare plate by adding 8ul of Super Master Mix (not containing DNA) to each
empty well.
Pipette 2ul of ~5ng/ul DNA into each well containing Super Master Mix; combine by
pipetting up and down.
Prepare plate to have all standards and samples in triplicate reactions wells.
Centrifuge plate at low speed for as long as necessary to remove large bubbles.

D. StepOne System
1. Open the StepOne software to begin a new experiment and select Advanced Setup
2. Use Quantification-Standard Curve as experiment type, TaqMan Reagents for target
sequence reagents, and Standard(~2 hours to complete run) for ramp speed.
3. Define three targets using MinorArc with Reporter FAM and Quencher NFQ-MGB,
MajorArc with Reporter NED and Quencher NFQ-MGB, and RNAseP with Reporter
VIC and Quencher None.
4. Define samples.
5. Under Run Method: Set Holding Stage for 10:00 at 95C, and 40 Cycles of 95C for 15
seconds, 55C for 15 seconds, and 60C for 60 seconds.
6. Once Run is complete, Go to Analysis Settings. Under CT Settings, deselect “Use
Default Settings” and set the Thresholds as: 0.1 for RNAseP, 0.1 for MinorArc, and
0.05 for MajorArc. Apply new Analysis Settings.
7. If Standard Deviation is greater than 0.5 for any of the three targets among triplicate
samples, identify and eliminate well that produces high Standard Deviation.
Additionally, if CV% is higher than 15 for triplicate samples, eliminate one of the
wells and use only duplicate sample measurements.
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E. Standard Curve Calculations
1. Linearity
• Plot the standard curve with average CT of triplicate wells for each target on
the Y-axis and log DNA added to each reaction on the X-axis. Add trend line
to each target across standards and add R2 values. R2 values are considered
acceptable at >0.99.
2. Slope
• The amplification efficiencies of each target may be calculated using the slope
of each trend line across standards. The formula for efficiency of each target is
calculated by the following formula: E=10^(-1/slope), where the slope is
calculated across all standard. Amplification efficiencies are considered
acceptable between 90-105%.
F. Mitochondrial Copy Number and Deletion Calculation
1. For each reaction per well, use the following formula to determine Mitochondrial
Copy (MtCopy):
• 2^(meanCT), where CT=(RNAseP CT- MinorArc CT)
• CT differences are found per reaction and averages were based on CTs from
triplicate measurements
2. For each reaction per well, use the following formula to determine Mitochondrial
Deletions (MtDeletion):
• 2^(meanCT), where CT=(MinorArc CT- MajorArc CT)
• CT differences are found per reaction and averages were based on CTs from
triplicate measurements
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APPENDIX II
PARENT PHTHALATE DIESTER AND ALTERNATIVE STRUCTURES
HMW

i. Di(2-ethylhexyl) phthalate (DEHP)
C28H38O4

ii. Diisononyl phthalate (DINP)
C26H42O4

iii. Benzyl butyl phthalate (BzBP)
C19H20O4

iv. Dioctyl Phthalate (DOP)
C24H34O8
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v. Diisodecyl phthalate (DIDP)
C28H46O4
LMW

i. Di-n-Butyl phthalate (DBP)
C16H22O4

ii. Di-iso-butyl Phthalate (DiBP)
C16H22O4

iii. Di-methyl phthalate (DMP)
C10H10O4

iv. Di-ethyl Phthalate (DEP)
C12H14O4
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Phthalate Alternative

i. Di-isononyl cyclohexane-1,2-dicarboxylate(DiNCH)
C26H48O4
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